Literature DB >> 8412626

Cloning of two distinct hemolysin genes from Porphyromonas (Bacteroides) gingivalis in Escherichia coli.

T Karunakaran1, S C Holt.   

Abstract

Hemolysin is considered a potent virulence factor in a large number of Gram-positive and Gram-negative bacterial pathogens. The hemolysin produced by the oral pathogen Porphyromonas gingivalis functions to provide the cell with its required heme-containing molecules for growth in the periodontal pocket. Two distinct P. gingivalis genes, each of which confers a hemolytic phenotype in Escherichia coli, were isolated by screening genomic DNA libraries of P. gingivalis on sheep blood agar plates. The results obtained from physical maps and Southern blots indicated a considerable degree of divergence in the nucleotide sequences of these two genes. Maxicell analyses of the recombinant plasmids in E. coli suggested that plasmid pPGH5 encoded a polypeptide of molecular weight 48 kDa, while an 18-kDa polypeptide was obtained with pPGH1 and pPGH7. When E. coli harboring these hemolysin genes were subjected to iron starvation, the levels of hemolysin activity increased. Biochemical characterization of hemolytic activities indicated that the activity of both hemolysins was inhibited by Mg2+ and Ca2+; but not by EDTA. Elevated levels of hemolytic activity were obtained from the E. coli recombinant strains in the presence of glutathione, DTT and 2-mercaptoethanol. Cholesterol inhibited the activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412626     DOI: 10.1006/mpat.1993.1055

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  12 in total

1.  The vimE gene downstream of vimA is independently expressed and is involved in modulating proteolytic activity in Porphyromonas gingivalis W83.

Authors:  Elaine Vanterpool; Francis Roy; Hansel M Fletcher
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Inactivation of vimF, a putative glycosyltransferase gene downstream of vimE, alters glycosylation and activation of the gingipains in Porphyromonas gingivalis W83.

Authors:  Elaine Vanterpool; Francis Roy; Hansel M Fletcher
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Antibacterial action of polyphosphate on Porphyromonas gingivalis.

Authors:  Ji-Hoi Moon; Jae-Hong Park; Jin-Yong Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

4.  Interactions of Porphyromonas gingivalis with oxyhaemoglobin and deoxyhaemoglobin.

Authors:  John W Smalley; Andrew J Birss; Robert Withnall; Jack Silver
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

5.  Cloning and characterization of a Prevotella melaninogenica hemolysin.

Authors:  H E Allison; J D Hillman
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Transformation and expression of a cloned fimA gene in Porphyromonas gingivalis.

Authors:  Y Takahashi; D Kato; N Hamada; H Yoshimoto; T Umemoto
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Isolation and characterization of a hemin-regulated gene, hemR, from Porphyromonas gingivalis.

Authors:  T Karunakaran; T Madden; H Kuramitsu
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

8.  vimA gene downstream of recA is involved in virulence modulation in Porphyromonas gingivalis W83.

Authors:  H Abaibou; Z Chen; G J Olango; Y Liu; J Edwards; H M Fletcher
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Involvement of extracytoplasmic function sigma factors in virulence regulation in Porphyromonas gingivalis W83.

Authors:  Yuetan Dou; Devon Osbourne; Rachelle McKenzie; Hansel M Fletcher
Journal:  FEMS Microbiol Lett       Date:  2010-08-27       Impact factor: 2.742

10.  Cloning and characterization of hemolytic genes from Helicobacter pylori.

Authors:  E S Drazek; A Dubois; R K Holmes; D Kersulyte; N S Akopyants; D E Berg; R L Warren
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.